Syra Health Corp.

SYRA · OTC Markets OTCQB · Stock · Healthcare
$0.83
+3.75% today
Delayed price,

What Syra Health does

Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education and training, and healthcare workforce development and staffing in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering targeted assignments, education, and monitoring symptoms, as well as providing interventions, such as cognitive behavioral therapy and mindfulness techniques; digital health products, including SyraBot, a chatbot to foster connectivity and engagement throughout individuals' care journeys offering members access to necessary information via its AI-powered customer support chat system; and CarePlus, an electronic medical records solution for small to mid-sized healthcare organizations. It also provides analytics as a service, analytics as a service, epidemiology, and health equity analytics solutions. In addition, the company offers medical communications, patient education, and healthcare training; and recruits nurses and allied health professionals for long-term fixed contract positions at hospitals and healthcare facilities. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The company was incorporated in 2020 and is headquartered in Carmel, Indiana.

Key facts

Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$11.8M
P/E (ttm)
—
Forward P/E
-2.7
Dividend yield
0.00%
Beta
3.37
Profit margin
1.6%
Employees
38
Headquarters
Carmel, IN, United States
Exchange
OTC Markets OTCQB

Performance

1 Month
-3.5%
3 Months
+2.7%
6 Months
+107.5%
1 Year
+773.7%
5 Years
-34.1%
$0.0652-week range$1.15
Biggest setback — last 12 months
-36.8%
13 Oct 2025 → 8 Dec 2025
Fell from $0.10 to $0.06 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+1466.7%
8 Dec 2025 → 7 Sept 2026
Ran from $0.06 to $0.94 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$0.55 (-33.3%)$0.83$1.24 (+49.9%)
3 Months$0.41 (-50.4%)$0.83$1.67 (+101.6%)
6 Months$0.31 (-62.9%)$0.83$2.24 (+169.5%)
12 Months$0.20 (-75.4%)$0.83$3.37 (+306.3%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 140.2%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 173,392 shares — Prasad Priya, COO and CFO · 2026-09-02
Acquired 368,458 shares — Alexander Gregory R., CEO · 2026-08-14
Acquired 110,537 shares — Alexander Gregory R., CEO · 2026-02-03
Acquired 43,348 shares — Reddy Vijayapal, Director · 2025-11-25
Acquired 43,348 shares — Paranjape Ketan, Director · 2025-11-25
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.